CME Group (CME) PT Raised to $300 at TD Cowen on 'Broadening Growth Drivers'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mail
Get Alerts CME Hot Sheet
Rating Summary:
14 Buy, 11 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 46
Join SI Premium – FREE
TD Cowen analyst Bill Katz raised the price target on CME Group (NASDAQ: CME) to $300.00 (from $292.00) while maintaining a Buy rating.
The analyst commented: "Broadening Growth Drivers - Management Meeting Takes; We affirm our Buy rating, raise our '26-27E adj. EPS and lift our 12M price target $8 to $300 post TD Cowen-sponsored investor meetings with senior management, truing up for 3Q ADV/ stronger outlook and higher repurchase. Concurrently, we lift our preference on CME among our Exchanges ranks.
Affirm Buy; lift 12M price target $8 to $300, reflecting higher earnings expectations. We move CME up our relative ranks w/in Exchanges."
You May Also Be Interested In
- Bloom Energy shares fall despite beating Q3 estimates
- Associated Banc-Corp (ASB) Tops Q3 EPS by 4c
- Selective Insurance Group (SIGI) Tops Q3 EPS by 47c; offers guidance
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Cowen & Co, Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
